Titolo |
Pubblicato in |
Anno |
Does the HFA/ICOS tool overestimate the risk of cardiovascular toxicities in oncologic patients scheduled to receive anti-VEGF agents? |
JOURNAL OF CARDIOVASCULAR MEDICINE |
2022 |
Serum uric acid / serum creatinine ratio as a predictor of cardiovascular events. Detection of prognostic cardiovascular cut-off values |
JOURNAL OF HYPERTENSION |
2022 |
Updated Recommendations on Cardiovascular Prevention in 2022. An Executive Document of the Italian Society of Cardiovascular Prevention |
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION |
2022 |
Correction to .updated recommendations on cardiovascular prevention in 2022: an executive document of the italian society of cardiovascular prevention |
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION |
2022 |
Clinical characteristics and outcomes of patients with COVID-19 infection: the results of the SARS-RAS Study of the Italian Society of Hypertension |
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION |
2021 |
High heart rate amplifies the risk of cardiovascular mortality associated with elevated uric acid |
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY |
2021 |
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study |
JOURNAL OF HYPERTENSION |
2021 |
Prevalence and clinical characteristics of isolated systolic hypertension in young: analysis of 24 h ambulatory blood pressure monitoring database |
JOURNAL OF HUMAN HYPERTENSION |
2021 |
ARB-Based Combination Therapy for the Clinical Management of Hypertension and Hypertension-Related Comorbidities: A Spotlight on Their Use in COVID-19 Patients |
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION |
2021 |
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project |
JN. JOURNAL OF NEPHROLOGY |
2021 |
The importance of including uric acid in the definition of metabolic syndrome when assessing the mortality risk |
CLINICAL RESEARCH IN CARDIOLOGY |
2021 |
A plea for smoking-free policies in COVID-19 times: cardiovascular prevention as an ally in coronavirus containment |
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION |
2021 |
Hypertension Management and Control in Italy. A Real-World Survey in Elderly Patients |
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION |
2021 |
Trehalose, a natural disaccharide, reduces stroke occurrence in the stroke-prone spontaneously hypertensive rat |
PHARMACOLOGICAL RESEARCH |
2021 |
Sacubitril/Valsartan as a therapeutic tool across the range of Heart Failure phenotypes and ejection fraction spectrum |
FRONTIERS IN PHYSIOLOGY |
2021 |
Identification of a plausible serum uric acid cut-off value as prognostic marker of stroke. the Uric Acid Right for Heart Health (URRAH) study |
JOURNAL OF HUMAN HYPERTENSION |
2021 |
Home blood pressure and telemedicine: a modern approach for managing hypertension during and after COVID-19 pandemic |
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION |
2021 |
Ventriculo-arterial coupling in the intensive cardiac care unit: a non-invasive prognostic parameter |
INTERNATIONAL JOURNAL OF CARDIOLOGY |
2021 |
The association of uric acid with mortality modifies at old age: data from the uric acid right for heart health (URRAH) study |
JOURNAL OF HYPERTENSION |
2021 |
Comparison of cardiovascular risk scores to predict anthracycline-induced cardiotoxicity in early breast cancer patients |
EUROPEAN HEART JOURNAL SUPPLEMENTS |
2021 |